FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/093328 [Registered on: 20/08/2025] Trial Registered Prospectively
Last Modified On: 18/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFECT OF ERANDADI TAILA AND BALA TAILA MATRA BASTI IN MANAGEMENT OF SUKHAPRASAV 
Scientific Title of Study   A comparative clinical study to evaluate the effect of erandadi taila and bala taila matra basti in the management of sukhaprasav 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Trisha Verma 
Designation  PG Schlor 
Affiliation  shree babu singh jai singh ayurvedic pg medical college 
Address  shree babu singh jai singh ayurvedic pg medical college and hospital fathegarh farrukhabaad
Balaganj lucknow
Lucknow
UTTAR PRADESH
209602
India 
Phone  7651838942  
Fax    
Email  trishav206@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Salim musa mulla 
Designation  Professor and HOD 
Affiliation  Shri Babu Singh Jay Singh Ayurvedic Medical College and Hospital 
Address  Bhaupur Shri Babu Singh Jay Singh Ayurvedic Medical College and Hospital Bhaupur Farrukhabad
Shri Babu Singh Jay Singh Ayurvedic Medical College and Hospital Bhaupur Farrukhabad
Farrukhabad
UTTAR PRADESH
209602
India 
Phone  7588627408  
Fax    
Email  drsmmulla@hotmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Trisha Verma 
Designation  PG scholar 
Affiliation  Shri Babu Singh Jay Singh Ayurvedic Medical College and Hospital 
Address  shree babu singh jai singh ayurvedic pg medical college and hospital farukhabaad
lucknow balaganj
Lucknow
UTTAR PRADESH
209602
India 
Phone  07651838942  
Fax    
Email  trishav206@gmail.com  
 
Source of Monetary or Material Support  
Shri Babu Singh Jay Singh Ayurvedic Medical College and Hospital Farrukhabad 209602 Uttarpradesh India 
 
Primary Sponsor  
Name  Dr Trisha Verma 
Address  Shri Babu Singh Jay Singh Ayurvedic Medical College and Hospital Bhaupur Farrukhabad 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Trisha Verma  Shri Babu Singh Jay Singh Ayurvedic Medical College And Hospital  Room 6, division no 2, Department of striroga and prasuti tantra
Farrukhabad
UTTAR PRADESH 
7651838942

trishav206@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
shri babu singh jay singh ayurvedic medical college   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  fair 
Patients  (1) ICD-10 Condition:O80||Encounter for full-term uncomplicated delivery. Ayurveda Condition: PRAJAYANI-PRAJANANAKALAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: erndadi taila, Reference: Bhaishajya Ratnavali, Route: Rectal, Dosage Form: Taila, Dose: 60(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Balataila, Reference: bhaishajya Ratnavali, Route: Rectal, Dosage Form: Taila, Dose: 60(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  35.00 Year(s)
Gender  Female 
Details  Primigravida
completed 37 weeks
uncomplicated cases of pregnancy
single intrauterine gestation
with adequate pelvis
pregnant women willing for the trial 
 
ExclusionCriteria 
Details  Pregnant women not willing for trial.
History of medical disorders during pregnancy such as; gestational diabetes mellitus
,pulmonary disease, renal disease, thyroid disorders, psychiatric illness, cardiac disease,
epilepsy, pre- eclampsia, eclampsia, malaria and HIV,bad obstetric history.

Absolute indication of caesarean section such as; central placenta praevia, contracted pelvis or
cephalo pelvic disproportion, pelvic mass, advanced carcinoma cervix and vaginal obstruction.
4. Anorectal diseases-fissure,hemorrhoids,fistula. 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
NORMAL DELEVERED BABY WITHOUT COMPLICATION.  7 DAYS 
 
Secondary Outcome  
Outcome  TimePoints 
NORMAL DELEVERED BABY WITHOUT COMPLICATION.  24hr to 36hr 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="2"
Days="15" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   when i give matra basti to our inclusive patient for 7 days in full term at 37 weeks than i  want to compare my both drugs Erandadi  taila and Bala Taila  basti  effect during labour for normal delivery without any complication . 
Close